Search results for "suppression"

showing 10 items of 404 documents

Increased immunosuppressive function of CD4(+)CD25(+)Foxp3(+)GITR+ T regulatory cells from NFATc2((-/-)) mice controls allergen-induced experimental …

2012

The expansion of effector T cells is tightly controlled by transcription factors like nuclear factor of activated T cells (NFAT) family members that mediate early intracellular responses to T cell receptor-mediated signals. In this study we show that, after allergen challenge, NFATc2((-/-)) mice had augmented number of functionally intact CD4(+)CD25(++)GITR(++) T regulatory (T regs) cells in the lung. Anti-GITR antibody treatment inhibited T regulatory cell function and enhanced the number of activated lung CD4(+) T cells associated with increased IL-2 and pSTAT-5 in the airways of NFATc2((-/-)) mice in experimental allergic asthma. This agonistic treatment led to increased inflammation in …

NFATC2T cellImmunologyInflammationBiologyT-Lymphocytes RegulatoryInterleukin 21MiceTh2 CellsGlucocorticoid-Induced TNFR-Related ProteinmedicineImmunology and AllergyAnimalsIL-2 receptorLungImmunosuppression TherapyMice KnockoutNFATC Transcription FactorsInterleukin-2 Receptor alpha SubunitFOXP3NFATForkhead Transcription FactorsHematologyAllergensAsthmarespiratory tract diseasesDisease Models Animalmedicine.anatomical_structureImmunologyCD4 Antigensbiology.proteinCytokinesTh17 CellsFemalemedicine.symptomAntibodySpleenImmunobiology
researchProduct

Risk factors and interventional strategies for BK polyomavirus infection after renal transplantation.

2012

BK virus (BKV)-induced viraemia after renal transplantation can be associated with severe impairment of graft function. This study evaluated possible risk factors for BKV replication and examined the outcomes following various currently used treatment approaches.Fifty-seven renal transplant recipients with BKV viraemia were retrospectively compared with 71 BKV-negative recipients to identify risk factors for BKV viraemia. Furthermore, outcome and graft function in 14 patients with BKV replication, in whom mycophenolate mofetil (MMF) was discontinued with a dose reduction of the remaining immunosuppressants, were compared with 32 patients in whom both MMF and the additional immunosuppressant…

NephrologyAdultMalemedicine.medical_specialtyvirusesUrologyLymphocytemedicine.medical_treatmentPrednisoloneAnti-Inflammatory AgentsKaplan-Meier Estimatemedicine.disease_causeVirus ReplicationGastroenterologyTacrolimusRisk FactorsInternal medicineConfidence IntervalsOdds RatioMedicineHumansLymphocyte CountWarm IschemiaRetrospective StudiesPolyomavirus Infectionsbusiness.industryGraft Survivalvirus diseasesImmunosuppressionOdds ratioMiddle AgedMycophenolic AcidViral LoadKidney TransplantationTacrolimusBK virusTransplantationTumor Virus Infectionsmedicine.anatomical_structureNephrologyBK VirusImmunologyCyclosporineDrug Therapy CombinationFemalebusinessViral loadImmunosuppressive AgentsScandinavian journal of urology and nephrology
researchProduct

Imūnsupresīvās terapijas radītās neiroloģiskās blaknes pacientiem pēc nieru transplantācijas

2017

Mērķis: Neiroloģiskas blaknes dažādām imūnsupresīvām zālem nav daudz pētītas un iespējamo blakņu incidences un smaguma atšķirību identifikācia var palīdzēt optimizēt terapiju, lai palīdzētu uzlabot pacientu dzīves kvalitāti pēc transplatācijas. Šī pētījuma mērķis ir salīdzināt incidenci un smagumu neiroloģiskām blaknēm pacientiem, kuri saņem dažāda veida imūnsupresīvu terapiju pēc nieres pārstādīšanas un izvērtēt blakņu incidenci starp sieviešu un vīriešu dzimumiem. Metodes: Pētījums tika viekts Rīgas Paula Stradiņa Klīniskajā Universitātes Slimnīcā ambulatorajā nieru transplantāciju nodaļā. Pētījuma populācija sastāvēja no pacientiem, kuri vismaz sešus mēnešus pēc nieru transplantācijas sa…

NeurotoxicityNeurologic side effectsKidney TransplantationImmunosuppressionTacrolimusMedicīna
researchProduct

First Results on the Scalar WIMP-Pion Coupling, Using the XENON1T Experiment

2018

We present first results on the scalar coupling of weakly interacting massive particles (WIMPs) to pions from 1 t yr of exposure with the XENON1T experiment. This interaction is generated when the WIMP couples to a virtual pion exchanged between the nucleons in a nucleus. In contrast to most nonrelativistic operators, these pion-exchange currents can be coherently enhanced by the total number of nucleons and therefore may dominate in scenarios where spin-independent WIMP-nucleon interactions are suppressed. Moreover, for natural values of the couplings, they dominate over the spin-dependent channel due to their coherence in the nucleus. Using the signal model of this new WIMP-pion channel, …

Nuclear TheoryPhysics::Instrumentation and DetectorsNuclear TheoryGeneral Physics and Astronomy01 natural sciencesHigh Energy Physics - ExperimentHigh Energy Physics - Experiment (hep-ex)High Energy Physics - Phenomenology (hep-ph)WIMPPions[PHYS.HEXP]Physics [physics]/High Energy Physics - Experiment [hep-ex]Nuclear ExperimentS030UDMPhysicsStarke Wechselwirkung und exotische Kerne – Abteilung BlaumAstrophysics::Instrumentation and Methods for AstrophysicsnucleonsuppressionHigh Energy Physics - PhenomenologyWeakly interacting massive particlesmedicine.anatomical_structureWeakly interacting massive particlesNucleonCoherence (physics)Astrophysics - Cosmology and Nongalactic AstrophysicsWIMP nucleon: interactionParticle physicsCosmology and Nongalactic Astrophysics (astro-ph.CO)[PHYS.NUCL]Physics [physics]/Nuclear Theory [nucl-th]FOS: Physical sciencesWIMP: massspin: dependenceGravitation and Astrophysicsoperator: nonrelativisticDark matter Particle dark matter Pions Weakly interacting massive particles Dark matter detectorsNuclear Theory (nucl-th)PionParticle dark matter0103 physical sciencesmedicineDark mattercross section: upper limit010306 general physicsCouplingDark matter detectorsnucleusScalar (physics)coherenceDark Matter WIMP-Pion coupling Xenon Direct seartch[PHYS.HPHE]Physics [physics]/High Energy Physics - Phenomenology [hep-ph]High Energy Physics::Experiment[PHYS.ASTR]Physics [physics]/Astrophysics [astro-ph]Nucleus
researchProduct

Advances in surface ion suppression from RILIS: Towards the Time-of-Flight Laser Ion Source (ToF-LIS)

2016

Abstract We present results from the development towards the Time-of-Flight Laser Ion Source (ToF-LIS) aiming for the suppression of isobaric contaminants through fast beam gating. The capability to characterize high resistance ion sources has been successfully demonstrated. A ninefold selectivity gain has been achieved through suppression of surface ionized potassium, while maintaining >90% transmission for laser-ionized gallium using a thin wall graphite ionizer cavity combined with a fast beam gate. Initial results from the investigation of glassy carbon as a potential hot cavity ion source are presented. Power-cycle tests of a newly designed mount for fragile ion source cavities indicat…

Nuclear and High Energy PhysicsIon source developmentIon beamIon suppression in liquid chromatography–mass spectrometry01 natural sciencesISOLDElaw.inventionIonIon beam depositionlaw0103 physical sciencesDetectors and Experimental Techniques010306 general physicsInstrumentation010302 applied physicsRILISResonance laser ionizationbusiness.industryChemistryLaserIon sourceTime of flightOptoelectronicsPhysics::Accelerator PhysicsAtomic physicsbusinessBeam (structure)
researchProduct

Radioactivity control strategy for the JUNO detector

2021

JUNO is a massive liquid scintillator detector with a primary scientific goal of determining the neutrino mass ordering by studying the oscillated anti-neutrino flux coming from two nuclear power plants at 53 km distance. The expected signal anti-neutrino interaction rate is only 60 counts per day, therefore a careful control of the background sources due to radioactivity is critical. In particular, natural radioactivity present in all materials and in the environment represents a serious issue that could impair the sensitivity of the experiment if appropriate countermeasures were not foreseen. In this paper we discuss the background reduction strategies undertaken by the JUNO collaboration…

Nuclear and High Energy PhysicsPhysics - Instrumentation and DetectorsPhysics::Instrumentation and DetectorsNuclear engineeringMonte Carlo methodControl (management)measurement methodsFOS: Physical sciencesQC770-798Scintillator7. Clean energy01 natural sciencesNOPE2_2Nuclear and particle physics. Atomic energy. Radioactivity0103 physical sciences[PHYS.HEXP]Physics [physics]/High Energy Physics - Experiment [hep-ex]ddc:530Sensitivity (control systems)010306 general physicsPhysicsJUNOliquid [scintillation counter]010308 nuclear & particles physicsbusiness.industryDetectorSettore FIS/01 - Fisica Sperimentaleradioactivity [background]suppression [background]Instrumentation and Detectors (physics.ins-det)Monte Carlo [numerical calculations]Nuclear powerthreshold [energy]sensitivityNeutrino Detectors and Telescopes (experiments)GEANTNeutrinobusinessEnergy (signal processing)
researchProduct

Optimising the Collinear Resonance Ionisation Spectroscopy (CRIS) experiment at CERN-ISOLDE

2020

© 2019 The CRIS experiment at CERN-ISOLDE is a dedicated laser spectroscopy setup for high-resolution hyperfine structure measurements of nuclear observables of exotic isotopes. Between 2015 and 2018 developments have been made to improve the background suppression, laser-atom overlap and automation of the beamline. Furthermore, a new ion source setup has been developed for offline studies. Here we present the latest technical developments and future perspectives for the experiment. ispartof: Nuclear Instruments & Methods In Physics Research Section B-Beam Interactions With Materials And Atoms vol:463 pages:384-389 ispartof: location:SWITZERLAND, CERN, Geneva status: published

Nuclear and High Energy Physicshyperfine structuretutkimuslaitteetspektroskopiaCERN-ISOLDEhigh-resolution7. Clean energy01 natural sciencesNuclear physicsCRISIonization0103 physical sciencesDalton Nuclear InstitutePhysics::Atomic PhysicsNuclear Experiment010306 general physicsSpectroscopyInstrumentationHyperfine structurePhysicsLarge Hadron Collider010308 nuclear & particles physicsResonanceIon sourceResearchInstitutes_Networks_Beacons/dalton_nuclear_instituteBeamlineBackground suppressionlaser spectroscopycollinear resonance ionization spectroscopyPhysics::Accelerator PhysicsydinfysiikkaNuclear Instruments and Methods in Physics Research Section B: Beam Interactions with Materials and Atoms
researchProduct

Genes differentially expressed by Aspergillus carbonarius strains under ochratoxin A producing conditions

2010

Aspergillus carbonarius is an important ochratoxin A (OTA)-producing fungus that is responsible for toxin contamination of grapes and wine, coffee and cocoa. A suppression subtractive hybridization (SSH) approach was performed with two strains of A. carbonarius, antagonistic in their OTA-production ability, to identify genes whose expression is linked with the ability to produce OTA. BlastX analysis identified 109 differentially-expressed sequences putatively involved in the production of OTA, with significant similarities (Evalue < 10− 5) to sequences deposited in the NCBI non-redundant protein database. Of the 109 ESTs, 26% were involved in regulation processes, 15% corresponded to hypoth…

Ochratoxin AOchratoxin productionGrapesMolecular Sequence DataWineAspergillus carbonariusMicrobiologyOchratoxinsMicrobiologyFungal Proteinschemistry.chemical_compoundGene Expression Regulation FungalSSHMycotoxinOchratoxinWinebiologyAspergillus nigerfood and beveragesGeneral MedicineFungi imperfectiMycotoxinsbiology.organism_classificationOchratoxinsAspergilluschemistryGene identificationSuppression subtractive hybridizationFood Science
researchProduct

Posttransplant Management of Recipients Undergoing Liver Transplantation for Hepatocellular Carcinoma. Working Group Report From the ILTS Transplant …

2020

Although liver transplantation (LT) is the best treatment for patients with localized hepatocellular carcinoma (HCC), recurrence occurs in 6%-18% of patients. Several factors, particularly morphological criteria combined with dynamic parameters, known before LT modify this risk and combined in prediction models may be used to stratify patients at need of variable surveillance strategies. Additional variables though likely explain differences in recurrence rates in patients with the same pre-LT HCC status. One of these variables is possibly immunosuppression (IS). Once recurrence takes place, management is highly heterogenous. Within the International Liver Transplantation Society Consensus …

OncologyAblation Techniquesmedicine.medical_specialtyCarcinoma HepatocellularConsensusmedicine.medical_treatmentConsensus Development Conferences as TopicMEDLINE030230 surgeryLiver transplantationMedical OncologyRisk Assessment03 medical and health sciences0302 clinical medicineRisk FactorsInternal medicinemedicineHumansIn patientGrading (tumors)Societies MedicalPostoperative CareTransplantationbusiness.industryLiver NeoplasmsConsensus conferenceImmunosuppressionChemoradiotherapy Adjuvantmedicine.diseasePrognosisUnited StatesLiver TransplantationQuality of evidenceEuropeTreatment OutcomeHepatocellular carcinomaPractice Guidelines as Topic030211 gastroenterology & hepatologyNeoplasm Recurrence Localbusiness
researchProduct

A prospective randomised, open-labeled, trial comparing sirolimus-containing versus mTOR-inhibitor-free immunosuppression in patients undergoing live…

2010

Abstract Background The potential anti-cancer effects of mammalian target of rapamycin (mTOR) inhibitors are being intensively studied. To date, however, few randomised clinical trials (RCT) have been performed to demonstrate anti-neoplastic effects in the pure oncology setting, and at present, no oncology endpoint-directed RCT has been reported in the high-malignancy risk population of immunosuppressed transplant recipients. Interestingly, since mTOR inhibitors have both immunosuppressive and anti-cancer effects, they have the potential to simultaneously protect against immunologic graft loss and tumour development. Therefore, we designed a prospective RCT to determine if the mTOR inhibito…

OncologyCancer ResearchTime Factorsmedicine.medical_treatmentMedizinIntracellular Signaling Peptides and Proteins - antagonists & inhibitors metabolismKaplan-Meier Estimate312 Clinical medicineProtein-Serine-Threonine KinaseLiver transplantationTHERAPYStudy ProtocolImmunosuppressive Agentendothelial growth-factor renal-cell carcinoma tumor progression rapamycin cancer cyclosporine efficacy therapy target model0302 clinical medicineRENAL-CELL CARCINOMARisk FactorsRecurrenceSurgical oncologyMedicine and Health SciencesLiver Neoplasms - drug therapy enzymology mortality surgerySirolimuProspective StudiesTUMOR PROGRESSIONTransplantation Homologoueducation.field_of_studyliver transplantationTOR Serine-Threonine KinasesLiver NeoplasmsIntracellular Signaling Peptides and ProteinsImmunosuppressionhepatocellular carcinomalcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensCANCER3. Good healthEuropeMulticenter StudyTreatment OutcomeTARGETsirolimusOncologyLiver Neoplasm030220 oncology & carcinogenesisHepatocellular carcinomaRandomized Controlled TrialmTORCarcinoma Hepatocellular - drug therapy enzymology mortality surgery030211 gastroenterology & hepatologyImmunosuppressive AgentsRCTHumanmedicine.drugCanadamedicine.medical_specialtyCarcinoma HepatocellularTime FactoreducationPopulationLiver Transplantation - adverse effects mortalityProtein Serine-Threonine Kinaseslcsh:RC254-282Disease-Free Survival03 medical and health sciencesInternal medicineGeneticsmedicineTransplantation HomologousHumansComparative StudyRapamycinddc:610educationProtein-Serine-Threonine Kinases - antagonists & inhibitors metabolismKaplan-Meiers Estimatebusiness.industryRisk FactorAustraliaImmunosuppressive Agents - therapeutic useSirolimus - therapeutic useEFFICACYHumans; Liver Transplantation; Hepatocellular Carcinoma; Randomized Controlled Trial; RCT; Multicenter Study; Comparative Study; Rapamycin; mTOR; Sirolimusmedicine.diseaseSurgeryMODELTransplantationClinical trialProspective StudieIntracellular Signaling Peptides and ProteinSirolimusENDOTHELIAL GROWTH-FACTORCYCLOSPORINERAPAMYCINbusiness
researchProduct